Autolus Therapeutics (AUTL) Cost of Revenue: 2024-2025
Historic Cost of Revenue for Autolus Therapeutics (AUTL) over the last 1 years, with Sep 2025 value amounting to $28.6 million.
- Autolus Therapeutics' Cost of Revenue was N/A to $28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.4 million, marking a year-over-year change of. This contributed to the annual value of $11.4 million for FY2024, which is N/A change from last year.
- As of Q3 2025, Autolus Therapeutics' Cost of Revenue stood at $28.6 million, which was up 17.17% from $24.4 million recorded in Q2 2025.
- Autolus Therapeutics' 5-year Cost of Revenue high stood at $28.6 million for Q3 2025, and its period low was $11.4 million during Q4 2024.
- Moreover, its 2-year median value for Cost of Revenue was $21.2 million (2025), whereas its average is $20.6 million.